Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pomar28
    Junior Member
    • Aug 2014
    • 1

    #1

    Trouble running rsem-prepare-reference

    I am working with non-model organism for which we have assembled draft genome, and annotated genes, in GFF3 format. I am trying to use RSEM to estimate gene/isoforms expression levels. Since RSEM does not support GFF3 format I converted GFF3 into GTF file. It looks to me that conversion worked fine, and here are the first few lines of converted GTF file:
    Scaffold1 I5K EXON 8888 9187 . + 0 gene_id "EAFF000001"; transcript_id "EAFF000001-RA";
    Scaffold1 I5K EXON 20235 20765 . + 0 gene_id "EAFF000001"; transcript_id "EAFF000001-RA";
    Scaffold1 I5K EXON 20965 21120 . + 0 gene_id "EAFF000001"; transcript_id "EAFF000001-RA";
    Scaffold1 I5K EXON 22857 22885 . + 0 gene_id "EAFF000001"; transcript_id "EAFF000001-RA";
    Scaffold1 I5K EXON 23931 24107 . + 0 gene_id "EAFF000001"; transcript_id "EAFF000001-RA";
    Scaffold1 I5K EXON 24723 24892 . + 0 gene_id "EAFF000001"; transcript_id "EAFF000001-RA";
    However my GTF is not correctly "understood" by RSEM, because rsem-prepare-reference doesn’t extract transcript reference sequences from sequence of the genome.
    When I run the ollowing command line:
    rsem-prepare-reference --gtf /EAFFGENOME/EAFF.Models_2.gtf --bowtie --bowtie-path bowtie-1.0.1 /EAFFGENOME/Eaff_11172013.genome2.fa affinis1_refs

    I’ve got the following error:

    Parsed 200000 lines
    The reference contains no transcripts!

    Any help or suggestions would be appreciated very much.

    PM
  • mikep
    Member
    • Feb 2011
    • 45

    #2
    1) Change the phase from "0" to "." (may not make a difference, but it's what I use)
    2) Do you have features in the gtf of type "transcript" (as opposed to exon)?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Working...